Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endoglin/CD 105 may not be an optimal tumor endothelial treatment target.

× No keyword cloud information.

2 in total

1. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.

Authors: A W Griffioen; C A Damen; S Martinotti; G H Blijham; G Groenewegen
Journal: Cancer Res Date: 1996-03-01 Impact factor: 12.701

Review 2. Antibody-directed targeting of the vasculature of solid tumors.

Authors: P E Thorpe; F J Burrows
Journal: Breast Cancer Res Treat Date: 1995 Impact factor: 4.872

2 in total

4 in total

Review 1. Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy.

Authors: G Molema; L F de Leij; D K Meijer
Journal: Pharm Res Date: 1997-01 Impact factor: 4.200

Review 2. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Authors: Rakesh R Ramjiawan; Arjan W Griffioen; Dan G Duda
Journal: Angiogenesis Date: 2017-03-30 Impact factor: 9.596

3. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?

Authors: Focke Ziemssen; Rayime Wegner; Jürgen Wegner; Olcay Tatar; Daniela Süsskind; Faik Gelisken; Martin Rohrbach; Karl U Bartz-Schmidt; Salvatore Grisanti
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2006-03-08 Impact factor: 3.117

4. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer.

Authors: Ester Fonsatti; Michele Maio
Journal: J Transl Med Date: 2004-06-11 Impact factor: 5.531

4 in total